Xavier Dolcet

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.

Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.

Journal: Cancer communications (London, England)

Published: November 04, 2025

miR-424(322)~503 impairs colon cancer progression driven by PTEN deficiency.

miR-424(322)~503 impairs colon cancer progression driven by PTEN deficiency.

Journal: Cell death & disease

Published: August 21, 2025

Cytoplasmic cyclin D1 modulates brain cortex development.

Cytoplasmic cyclin D1 modulates brain cortex development.

Journal: Cellular and molecular life sciences : CMLS

Published: July 21, 2025

Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503.

Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503.

Journal: Cell death & disease

Published: April 11, 2025

Crucial role of the NSE1 RING domain in Smc5/6 stability and FANCM-independent fork progression.

Crucial role of the NSE1 RING domain in Smc5/6 stability and FANCM-independent fork progression.

Journal: Cellular and molecular life sciences : CMLS

Published: February 06, 2024

Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.

Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 12, 2023

In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.

In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 15, 2023

Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.

Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.

Journal: Cancer communications (London, England)

Published: September 13, 2022

Antitumor Effects of Ral-GTPases Downregulation in Glioblastoma.

Antitumor Effects of Ral-GTPases Downregulation in Glioblastoma.

Journal: International journal of molecular sciences

Published: June 29, 2022

The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.

The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.

Journal: Cellular and molecular life sciences : CMLS

Published: May 23, 2022

Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

Journal: Scientific reports

Published: March 18, 2022

Elimination of Vitamin D Signaling Causes Increased Mortality in a Model of Overactivation of the Insulin Receptor: Role of Lipid Metabolism.

Elimination of Vitamin D Signaling Causes Increased Mortality in a Model of Overactivation of the Insulin Receptor: Role of Lipid Metabolism.

Journal: Nutrients

Published: March 15, 2022

Showing 1-12 of 49

Last Updated: 09/26/2026